Skip Links

IMC Bringing Israeli Expertise
Into a Global Market

A Pharma Grade Medical Cannabis Brand Capturing
The Full Value Chain at Higher Margins

Play Video

Financial Overview

$1,644.89 Feb 12, 2019
Valuation at IPO $52.7B
IPO Share Price CAD$4
Founded Date2010
FoundersOren Shuster & Rafael Gabay
Number of Employees50

Funding Rounds

2 Funding Rounds

C$ 29.5M Total Funding Amount



Total Investments Amount

CSE Reports

2019Annual Financial Statements 201931/12/2019
q12019Quarterly Financial Statements Q1/201931/03/2019
q22019Quarterly Financial Statements Q2/201930/06/2019
See All Reports

Corporate Presentations

Corporate PresentationQ4 2020

News and Updates

October 11, 2020

IMC Applies to List its Common Shares on the NASDAQ Capital Market

October 8, 2020

IM Cannabis Accelerates Sales in Germany, Reaching Adjusted EBITDA Profitability

October 6, 2020

Israeli Ministry of Health Opens International Export Market for Israeli Medical Cannabis Producers

View All News

Technology and Innovation

Our Technology Innovation

IMC is one of the world & the most advanced cannabis cultivators. Utilizing a decade of cannabis growing.....

Read More About Our Technology Innovation